|
Online CME Activity
Breast Cancer - Many Risk Factors, but Few Modifiable
|
NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
Breast Cancer - Many Risk Factors, but Few Modifiable
2.00 AMA PRA Category 1 Credits™
Learning Objective
Participants should be able to list at least 3 non-modifiable breast cancer risk factors as well as identify at least 3 inclusion criteria for referral to genetic counseling.
Accreditation
This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 2.00 |
AMA PRA Category 1 Credits™ |
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Pri-Med Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
Faculty and Editorial Board
Written By:
Tracy Webb, PhD, Clinical Editor, Pri-Med Institute, Boston, MA;
Reviewed By:
Anne Hamburger, PhD, Professor, Pathology and Oncology, University of Maryland School of Medicine, Baltimore, MD;
Financial Disclosure Statement(s)
Dr. Hamburger has no significant relationships to disclose.
Dr. Webb holds stock in Millennium Pharmaceuticals.
Pri-Med Disclaimer
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
|
|
|
